Find the latest pharmaceutical market place for formulations enquiry about Flecainide on PharmaCompass.com.

Tender// Various Formulations needed in Mauritius [ENA05471]

A Mauritian Ministry of Health & Quality of life is looking for formulation suppliers for the tender. Mentioned below formulations are required with following registrations: PIC country/ GCC country/ Manufacturing site present either on the EUDRA GMP/ USFDA database.
1. Adenosine IV Injections (3mg/ml*2ml)- Qty: 3,600
2. Flecainide (100 mg Tablets- Preferably strip/blister pack)- Qty: 72,000
3. Sildenafil (50 mg Tablets- Preferably strip/blister pack)- Qty: 25,000

Reply

17 Oct 2019

Flecainide Acetate mini-tablets needed in Tunisia [ENA03508]

A private Tunisian laboratory that ensures the development, the manufacturing and the marketing of the generic drugs is looking for suppliers of Flecainide Acetate mini-tablets (sustained release).

Reply

22 Feb 2019

United_States_of_America Flag

Enquiry// Flecainide Acetate Tablets needed for the US market [ENA01739]

Inski Pharma Consultants LLC- a leading pharmaceutical company based in the United States is looking for the suppliers of Flecainide Acetate Tablets. Interested suppliers must contact Roberto Sroka via E-mail: rsroka.inskipharma@gmail.com or Tel: 3056082369.

Reply

01 Sep 2018

Enquiry// Flecainide 100 mg (500,000 tablets per year) needed in Albania [ENA00679]

A leading Albanian Pharmaceutical Manufacturing company is looking for suppliers/manufacturers of Flecainide 100 mg (500,000 tablets per year) for the domestic market. Concerning the registration of a pharmaceutical drug in Albania, there are some requirements as follows:
1. Dossier format in CTD (English) or for “Well-established medicines” in the format that it is possessed by the MAH.
2. The product should not only be approved, but also on the market in the exporting country (original CPP, issued not before 12 months before the application date).
3. GMP of the manufacturer of the finished product, copy with Apostille stamp in the country of origin, valid at the time of application, or legalized copy in the country of origin.
4. Marketing Authorization in the country of origin (notarized copy, translated into English in the country of origin)
5. Samples of the finished product from the country issuing the CPP, reference standard of API.

Reply

27 Jan 2018

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.